Shanghai Labway Clinical Laboratory Co., Ltd.
SZSE:301060.SZ
12.86 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -98.59 | -161.709 | 739.055 | 261.617 | 134.481 | 94.611 | 73.934 | -20.194 | 58.764 | 82.311 | 70.34 | 84.342 |
| Depreciation & Amortization
| 77.969 | 65.364 | 78.24 | 59.348 | 43.691 | 47.85 | 40.353 | 27.52 | 19.364 | 12.058 | 12.077 | 5.465 |
| Deferred Income Tax
| 0 | -18.712 | -16.738 | 0.678 | -4.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.72 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 81.784 | 452.413 | -983.47 | -123.547 | -29.477 | -99.094 | 47.883 | -129.437 | -54.822 | -44.849 | -176.367 | -91.6 |
| Accounts Receivables
| 218.806 | 1,060.648 | -1,522.3 | -298.027 | -82.464 | -57.512 | -35.372 | 0 | -57.317 | -51.348 | -156.082 | 0 |
| Inventory
| 9.432 | 14.838 | -273.176 | 0.69 | 21.939 | 2.275 | 8.175 | -48.377 | 2.496 | 6.499 | -41.719 | -48.44 |
| Accounts Payables
| 0 | -604.362 | 828.743 | 173.113 | 35.185 | 57.512 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -146.453 | -18.712 | -16.738 | 0.678 | -4.137 | -101.369 | 39.707 | -81.06 | 0 | 0 | -134.648 | -43.16 |
| Other Non Cash Items
| 155.15 | 209.633 | 250.342 | 26.093 | 19.18 | 27.236 | 22.624 | 26.591 | 3.829 | 30.177 | 11.178 | 3.422 |
| Operating Cash Flow
| 216.313 | 546.988 | 84.167 | 223.51 | 167.875 | 70.603 | 184.794 | -95.519 | 27.136 | 79.697 | -82.771 | 1.63 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -76.616 | -398.885 | -230.077 | -118.882 | -44.548 | -39.514 | -73.341 | -130.608 | -103.244 | -42.447 | -14.905 | -16.129 |
| Acquisitions Net
| 3.802 | -11.102 | 0.002 | 13.487 | 52.506 | -1.007 | 0.636 | -19.027 | -8.919 | -2.703 | 0 | 0 |
| Purchases Of Investments
| -232 | -240.421 | -305.213 | -941 | -439.328 | -600.77 | -1,432.002 | -950.45 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 230.63 | 247.358 | 710.663 | 650.981 | 559.64 | 702.938 | 1,416.665 | 670.569 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 5.602 | 4.552 | 4.679 | -7.993 | -44.548 | 15.845 | 4.411 | 0.982 | -23.979 | 0.809 | -14.905 | -5.411 |
| Investing Cash Flow
| -68.582 | -398.498 | 180.053 | -403.406 | 83.721 | 77.492 | -83.631 | -428.534 | -136.143 | -44.34 | -14.905 | -21.54 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -98.786 | 199.982 | 180.013 | 1.999 | 0 | -30 | -40 | -4.8 | 0 | 0 | -5 | 25 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -10.255 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -7.357 | -136.709 | -125.612 | -0.302 | -35.246 | -64.418 | -3.473 | -27.817 | -9.528 | -9.604 | -6.846 | -1.044 |
| Other Financing Activities
| -74.112 | -8.292 | -3.915 | 118.055 | -60.846 | -1.99 | 8.174 | 464.647 | 296.093 | -7.09 | 94.129 | 33.846 |
| Financing Cash Flow
| -180.254 | 44.726 | 50.485 | 119.752 | -96.111 | -96.407 | -35.3 | 432.03 | 286.565 | -16.693 | 82.283 | 57.802 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -0.57 | -0.556 | 0.02 | -0.239 | -0.533 | -0.61 | -0.101 | -0.032 | 0 | -0 | 0 |
| Net Change In Cash
| -32.523 | 192.647 | 314.149 | -60.125 | 155.246 | 51.154 | 65.254 | -92.124 | 177.526 | 18.663 | -15.394 | 37.892 |
| Cash At End Of Period
| 825.747 | 858.271 | 665.624 | 351.475 | 411.6 | 256.354 | 205.2 | 139.946 | 232.948 | 55.423 | 36.76 | 52.153 |